| | | | | | | |
 | VERTEX PHARMACEUTICALS | 0.13% | 4.25% | 11.31% | 40.85% | 41.38% | 82 513 |
| REGENERON PHARMACEUTICALS, INC. | 0.07% | 3.74% | 2.96% | 22.03% | 118.85% | 79 336 |
| BEIGENE, LTD. | -0.70% | -2.48% | 18.12% | 28.04% | 61.83% | 27 008 |
 | GENMAB A/S | 0.15% | -3.07% | -9.69% | 23.13% | 76.54% | 25 338 |
 | ARGENX SE | -1.20% | -2.50% | -0.49% | 48.76% | 167.23% | 20 815 |
| SAREPTA THERAPEUTICS, INC. | -1.27% | -5.63% | -5.16% | 83.75% | 10.10% | 10 788 |
| NEUROCRINE BIOSCIENCES, INC. | -0.12% | -2.79% | -9.37% | 49.41% | 9.73% | 10 407 |
| LEGEND BIOTECH CORPORATION | -2.10% | -2.80% | 5.59% | 47.32% | --.--% | 8 824 |
| ASCENDIS PHARMA A/S | 0.80% | -0.42% | 0.30% | 6.51% | -9.95% | 6 860 |
| HALOZYME THERAPEUTICS, INC. | -4.82% | -1.46% | -10.88% | 58.62% | 164.53% | 6 857 |
| KARUNA THERAPEUTICS, INC. | 0.41% | 2.56% | 0.19% | 92.64% | 97.20% | 6 765 |
 | REMEGEN CO., LTD. | 1.03% | 4.31% | 19.00% | 38.08% | --.--% | 6 004 |
| EXELIXIS, INC. | -1.36% | 4.42% | 8.92% | 0.29% | -1.52% | 5 635 |
| AKESO, INC. | 0.99% | 6.69% | 18.60% | 141.13% | --.--% | 5 479 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | 4.52% | 4.84% | 9.16% | 46.20% | --.--% | 5 379 |
| | | | | | | |
| | Media | -0.23% | 0.64% | 3.90% | 48.45% | 66.90% | |
| | Media ponderata per Capi. | -0.17% | 1.47% | 5.01% | 37.78% | 77.40% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
